NO882959D0 - Fremgangsmaate for fremstilling av hoeyrevridende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)tiazol-7-karboksylsyre. - Google Patents

Fremgangsmaate for fremstilling av hoeyrevridende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)tiazol-7-karboksylsyre.

Info

Publication number
NO882959D0
NO882959D0 NO882959A NO882959A NO882959D0 NO 882959 D0 NO882959 D0 NO 882959D0 NO 882959 A NO882959 A NO 882959A NO 882959 A NO882959 A NO 882959A NO 882959 D0 NO882959 D0 NO 882959D0
Authority
NO
Norway
Prior art keywords
tiazol
determinating
pyrrolo
pyridyl
procedure
Prior art date
Application number
NO882959A
Other languages
English (en)
Other versions
NO882959L (no
Inventor
Gerard Rajoharison Harivelo
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO882959D0 publication Critical patent/NO882959D0/no
Publication of NO882959L publication Critical patent/NO882959L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO88882959A 1987-07-02 1988-07-01 Fremgangsmaate for fremstilling av hoeyrevridende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)tiazol-7-karboksylsyre. NO882959L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8709376A FR2617484B1 (fr) 1987-07-02 1987-07-02 Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre

Publications (2)

Publication Number Publication Date
NO882959D0 true NO882959D0 (no) 1988-07-01
NO882959L NO882959L (no) 1989-01-03

Family

ID=9352790

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88882959A NO882959L (no) 1987-07-02 1988-07-01 Fremgangsmaate for fremstilling av hoeyrevridende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)tiazol-7-karboksylsyre.

Country Status (24)

Country Link
US (1) US4906757A (no)
EP (1) EP0297987A1 (no)
JP (1) JP2571828B2 (no)
KR (1) KR890002193A (no)
AU (1) AU600838B2 (no)
BG (1) BG48810A3 (no)
CA (1) CA1298839C (no)
CS (1) CS272240B2 (no)
DD (1) DD271330A5 (no)
DK (1) DK367388A (no)
FI (1) FI95801C (no)
FR (1) FR2617484B1 (no)
HU (1) HU198073B (no)
IE (1) IE65279B1 (no)
IL (1) IL86919A (no)
MA (1) MA21305A1 (no)
MX (1) MX168612B (no)
NO (1) NO882959L (no)
NZ (1) NZ225261A (no)
PL (1) PL157527B1 (no)
PT (1) PT87907B (no)
SU (1) SU1579463A3 (no)
TN (1) TNSN88070A1 (no)
ZA (1) ZA884746B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DK0595924T3 (da) * 1991-07-17 1999-11-01 Abbott Lab Antagonister for blodpladeaktiverende faktorer
DE10004157A1 (de) 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
CN106543204A (zh) * 2016-11-08 2017-03-29 清华大学 一种合成多取代吡咯并[1,2‑c]噻唑衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NZ225261A (en) 1989-12-21
FI95801C (fi) 1996-03-25
DD271330A5 (de) 1989-08-30
HUT47588A (en) 1989-03-28
SU1579463A3 (ru) 1990-07-15
MA21305A1 (fr) 1988-12-31
PT87907A (pt) 1989-06-30
US4906757A (en) 1990-03-06
CA1298839C (fr) 1992-04-14
CS272240B2 (en) 1991-01-15
IE882015L (en) 1989-01-02
PL157527B1 (pl) 1992-06-30
FI883167A (fi) 1989-01-03
TNSN88070A1 (fr) 1990-07-10
JP2571828B2 (ja) 1997-01-16
FR2617484A1 (fr) 1989-01-06
HU198073B (en) 1989-07-28
DK367388D0 (da) 1988-07-01
BG48810A3 (en) 1991-05-15
KR890002193A (ko) 1989-04-08
PT87907B (pt) 1995-06-30
CS476288A2 (en) 1990-03-14
JPS6429382A (en) 1989-01-31
MX168612B (es) 1993-06-01
IL86919A0 (en) 1988-11-30
FR2617484B1 (fr) 1989-10-20
AU1851288A (en) 1989-01-05
IE65279B1 (en) 1995-10-18
PL273372A1 (en) 1989-03-06
EP0297987A1 (fr) 1989-01-04
DK367388A (da) 1989-01-03
NO882959L (no) 1989-01-03
FI883167A0 (fi) 1988-07-01
FI95801B (fi) 1995-12-15
AU600838B2 (en) 1990-08-23
ZA884746B (en) 1989-03-29
IL86919A (en) 1992-02-16

Similar Documents

Publication Publication Date Title
NO881482D0 (no) Fremgangsmaate for fremstilling av substituerte di-t-butylfenoler.
NO883813D0 (no) Fremgangsmaate for fremstilling av homopolyamider.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO882959D0 (no) Fremgangsmaate for fremstilling av hoeyrevridende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)tiazol-7-karboksylsyre.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO880338D0 (no) Fremgangsmaate for fremstilling av cycloalkan (1,2-c:4,3-c)dipyrazole.
NO890247D0 (no) Fremgangsmaate for fremstilling av 3-(3-pyridyl)-1h, 3h-pyrrolo-(1,2-c)tiazol-7-karbonitril.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO880127D0 (no) Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO913388D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO883525D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO883526D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO913422L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO890778L (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrederivater.
NO871521L (no) Fremgangsmaate for fremstilling av benzoksa- henholdsvis benzotia-diazolderivater.
NO922254D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO922253L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO169281C (no) Fremgangsmaate for fremstilling av heksanitrostilben.